News
2 Apr 2020
KOLINPHARMA® obtains the patent in the United States of America for IVUXUR® - 17/6/2019
This is a further confirmation of the commitment of KOLINPHARMA® aimed at protecting and enhancing the know-how and investments made in R&D.
The obtaining of the patent, whose application had been filed at the end of 2015, will be valid on the US market until May 2036 and represents an important consolidation for the group's assets. A recognition that translates into a significant opportunity for the overseas extension of the product where the nutraceutical market recorded 23% growth in 2017 compared to 2014.
IVUXUR® is a food supplement, based on PACRAN® (dry cranberry extract), D-mannose, bearberry and zinc, intended to maintain the well-being of the urinary tract. It is a Kosher, Halal, Milk free, Doping Free certified product.
Mentioned Companies
Kolinpharma
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance